 |
|
|
| |
Efficacy and safety of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in virologically-suppressed HIV patients (EBONY Study)
|
| |
| |
EACS 2021 Oct 27-30
S. Cicalini1, P. Lorenzini1, E. Grilli1, M.M. Plazzi1, F. De Zottis1, M. Camici1, M. Fusto1, R. Gagliardini1, R. Bellagamba1, A. Antinori1
1National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, HIV/AIDS Unit, Rome, Italy
|
| |
|
|
|
|
|
